ArticleVirology2012

Topical gel formulation of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 confers protection against HIV-1 vaginal challenge in a humanized mouse model.

Milena Veselinovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.